Wolverine Trading’s Juno Therapeutics, Inc. JUNO Stock Holding History

Wolverine Trading’s Portfolio JUNO Stock Details JUNO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q1	–	Sell	-79,100	Closed	-$3.62M	–	6304
2017 Q4	$3.62M	Buy	+79,100	New	+$3.95M	0.01%	1077
2017 Q3	–	Sell	-24,700	Closed	-$746K	–	5478
2017 Q2	$746K	Buy	24,700 +10,400	+73%	+$257K	﹤0.01%	2035
2017 Q1	$314K	Sell	14,300 -400	-3%	-$8.58K	﹤0.01%	2967
2016 Q4	$277K	Buy	+14,700	New	+$360K	﹤0.01%	3351

Other funds holding JUNO

IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

Glenmede Trust Philadelphia, Pennsylvania $20.4B AUM

Wolverine Trading's JUNO Position: Q1 2018 in Review

Wolverine Trading sold out of Juno Therapeutics, Inc. (JUNO) in Q1 2018, closing a stake of 31,112 shares — an estimated $1.42M sold.

Wolverine Trading first reported a position in JUNO in Q4 2017 and held it in 1 quarter. The position peaked at $1.42M in Q4 2017. 2 funds tracked by Wall St. Rank hold JUNO as of Q1 2018.

Wolverine Trading reported no remaining Juno Therapeutics, Inc. position as of Q1 2018 after selling out during the quarter.
Wolverine Trading sold 31,112 Juno Therapeutics, Inc. shares in Q1 2018, an estimated $1.42M.
Wolverine Trading first reported a position in Juno Therapeutics, Inc. in Q4 2017 and held it in 1 quarter.
Wolverine Trading's Juno Therapeutics, Inc. position peaked at $1.42M in Q4 2017.
2 funds tracked by Wall St. Rank held Juno Therapeutics, Inc. as of Q1 2018.

Based on Wolverine Trading's 13F filing for Q1 2018, filed 15 May 2018.